Oncology Weekly News - April 28th 2025
🧬🚀 Oncology Breakthroughs You Can’t Miss: From groundbreaking survival data to…
ELCC 2025 Preview: Key Lung Cancer Highlights to Watch
ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…
Oncology Weekly Update - March 10th 2025
🏥Oncology Update: Imfinzi, TEVIMBRA, Taletrectinib & New Trials Welcome to…
AAD 2025 Preview: Key Dermatology Highlights to Watch
AAD 2025 at a glance With AAD 2025 on the horizon, here’s a preview of…
Oncology Weekly Update - March 3rd 2025
Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Vaccines & More This…
AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch
AAAAI 2025 at a glance As AAAAI 2025 approaches, LucidQuest highlights…
Oncology Weekly News - February 24th 2025
🏥 Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Trials & More This…
Oncology Weekly News - February 17th 2025
🏥 Oncology Update: Cancer Trials, Immunotherapy, PADCEV & KEYTRUDA This…
Oncology Weekly News - February 10th 2025
🏥 Oncology Advances: Radium-223, Pembrolizumab, Cabozantinib,…
Hematology Weekly News - February 10th 2025
Hematology Updates: Mim8, Breyanzi, Axi-Cel, Ziftomenib, CAR-T, DLBCL, MCL,…
Navigating the Immunoglobulin Therapy Landscape: An Overview
The Immunoglobulin Replacement Therapy (IG) market is growing, as these…
Coupling state-of-the-art technologies: CRISPR in the service of CAR-T immunotherapy
Cancer is the second leading cause of death worldwide. Many research and…
